Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus. 1999

K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
Department of Internal Medicine, Juntendo University School of Medicine, Tokyo, Japan.

CD80 and CD86 were detected in high amounts on circulating T cells in the peripheral blood of some patients with systemic lupus erythematosus (SLE), using flow cytometry and monoclonal antibodies. Patients with other connective tissue diseases did not have a high percentage of T cells expressing CD80 or CD86 in their peripheral blood. CD80 was expressed mainly on CD4 T cells, whereas CD86 was expressed on CD8 T cells, and these two populations were associated with particular clinical features. These two molecules were expressed on different T-cell populations and might have different roles in the generation and regulation of immune responses. Since high expression of CD86 on T cells was detected much earlier than the appearance of clinical features and a high titer of anti-DNA antibody, it may be a useful parameter for predicting the flare of SLE.

UI MeSH Term Description Entries
D007963 Leukocytes, Mononuclear Mature LYMPHOCYTES and MONOCYTES transported by the blood to the body's extravascular space. They are morphologically distinguishable from mature granulocytic leukocytes by their large, non-lobed nuclei and lack of coarse, heavily stained cytoplasmic granules. Mononuclear Leukocyte,Mononuclear Leukocytes,PBMC Peripheral Blood Mononuclear Cells,Peripheral Blood Human Mononuclear Cells,Peripheral Blood Mononuclear Cell,Peripheral Blood Mononuclear Cells,Leukocyte, Mononuclear
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003240 Connective Tissue Diseases A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides. Connective Tissue Disease,Disease, Connective Tissue,Diseases, Connective Tissue
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
June 1997, Clinical immunology and immunopathology,
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
January 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
January 1999, Scandinavian journal of immunology,
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
November 1998, Journal of clinical immunology,
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
May 2001, Annals of the rheumatic diseases,
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
January 2005, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban,
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
January 2005, The Egyptian journal of immunology,
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
January 1999, Autoimmunity,
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
September 2009, Clinical immunology (Orlando, Fla.),
K Abe, and Y Takasaki, and C Ushiyama, and J Asakawa, and T Fukazawa, and M Seki, and M Hirashima, and M Ogaki, and H Hashimoto
December 1975, The Keio journal of medicine,
Copied contents to your clipboard!